Latest Period
Q2 2026
Security Snapshot
Ginkgo Bioworks Holdings, Inc. - Class A Stock (DNA) Institutional Ownership
CUSIP: 37611X209
13F Institutional Holders and Ownership History from Q2 2024 to Q2 2026
Institutions Reporting
181
Shares (Excl. Options)
36,134,132
Price
$9.91
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Stock
- Symbol
- DNA on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 36,134,132
- Total 13F value
- $358,670,074
- Portfolio coverage rank
- 0%
- Share change
- +3,854,606
- Value change
- +$39,323,866
- Number of holders
- 181
- Shares outstanding
- 53,539,091
- SEC-reported price per share
- $7.83
- Insider filing price
- $7.83
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- DNA - Ginkgo Bioworks Holdings, Inc. - Class A Stock is tracked under CUSIP 37611X209.
- 181 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 171 to 181 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $196,984,561 to $358,670,074.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 181 institutions filings for Q2 2026.
Security key
37611X209
Latest holder period
Q2 2026
13F holders
181
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
DNA full holder history
Ginkgo Bioworks Holdings, Inc. SEC filings
Ginkgo Bioworks Holdings, Inc. company facts
Ginkgo Bioworks Holdings, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 37611X209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
DNA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Shetty Reshma P. | 9.5% | $34,804,700 | 4,716,084 | Reshma P. Shetty | 14 Feb 2025 | |||
| BlackRock, Inc. | 7.7% | +17% | $40,854,486 | +$11,107,904 | 4,122,510 | +37% | BlackRock, Inc. | 30 Jun 2026 |
| CASCADE INVESTMENT, L.L.C. | 7.5% | $52,803,453 | 3,621,636 | Cascade Investment, L.L.C. | 30 Sep 2025 | |||
| VIKING GLOBAL INVESTORS LP | 7.1% | $24,610,641 | 3,577,128 | VIKING GLOBAL INVESTORS LP | 31 Mar 2026 | |||
| BAILLIE GIFFORD & CO | 4.9% | $19,874,603 | 2,391,649 | BAILLIE GIFFORD & CO | 31 Dec 2025 | |||
| VANGUARD GROUP INC | 5.1% | +17% | $26,787,544 | +$4,135,129 | 2,381,115 | +18% | The Vanguard Group | 30 Jun 2025 |
| Che Austin | 5% | $17,509,589 | 2,372,573 | Austin Che | 31 Dec 2024 |
As of 30 Jun 2026, 181 institutional investors reported holding 36,134,132 shares of Ginkgo Bioworks Holdings, Inc. - Class A Stock (DNA). This represents 67% of the company’s total 53,539,091 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
57%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8% | 4,282,903 | +18% | 0% | $42,443,568 |
| VIKING GLOBAL INVESTORS LP | 6.7% | 3,577,128 | 0% | 0.1% | $35,449,338 |
| Erste Asset Management GmbH | 4.7% | 2,536,939 | +30% | 0.2% | $25,902,147 |
| BAILLIE GIFFORD & CO | 4.5% | 2,391,649 | 0% | 0.02% | $23,701,242 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 2,087,293 | +9% | 0% | $20,685,074 |
| Anchorage Capital Group, L.L.C. | 3.3% | 1,746,363 | 0% | 3.8% | $17,306,457 |
| Legal & General Group Plc | 3.1% | 1,669,419 | +0.47% | 0% | $16,543,944 |
| STATE STREET CORP | 2.8% | 1,472,370 | +9.3% | 0% | $14,591,187 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,222,016 | +21% | 0% | $12,112,753 |
| FORBES J M & CO LLP | 1.9% | 999,911 | -2.8% | 0.78% | $9,909,118 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.8% | 937,803 | +66% | 0% | $9,293,628 |
| Allianz Asset Management GmbH | 1.5% | 785,798 | +12% | 0.01% | $7,787,258 |
| UBS Group AG | 1.3% | 691,659 | +19% | 0% | $6,854,341 |
| MILLENNIUM MANAGEMENT LLC | 1.2% | 638,676 | +31% | 0% | $6,329,279 |
| AQR CAPITAL MANAGEMENT LLC | 1.2% | 621,625 | +111% | 0% | $6,160,304 |
| SB INVESTMENT ADVISERS (UK) LTD | 1.1% | 610,729 | 0% | 0.08% | $6,052,324 |
| GOLDMAN SACHS GROUP INC | 1.1% | 607,376 | -35% | 0% | $6,019,096 |
| BANK OF AMERICA CORP /DE/ | 1% | 545,852 | +14% | 0% | $5,409,393 |
| Prescott Group Capital Management, L.L.C. | 1% | 541,845 | 0% | 0.46% | $5,369,684 |
| RENAISSANCE TECHNOLOGIES LLC | 1% | 539,856 | +437% | 0.01% | $5,349,973 |
| NORTHERN TRUST CORP | 0.76% | 405,141 | +21% | 0% | $4,014,948 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.74% | 394,607 | +19% | 0% | $3,910,555 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.67% | 358,783 | +11% | 0.02% | $3,555,540 |
| DIMENSIONAL FUND ADVISORS LP | 0.66% | 351,200 | +176% | 0% | $3,480,392 |
| TUDOR INVESTMENT CORP ET AL | 0.63% | 335,710 | -28% | 0.01% | $3,326,886 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Latest
Q2 2026
Rows shown
1-9 of 9
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 36,134,132 | $358,670,074 | +$39,323,866 | $9.91 | 181 |
| 2026 Q1 | 32,332,811 | $196,984,561 | -$2,396,992 | $6.13 | 171 |
| 2025 Q4 | 32,523,473 | $270,289,076 | +$18,015,840 | $8.31 | 179 |
| 2025 Q3 | 30,173,943 | $436,957,795 | -$36,412,391 | $14.58 | 171 |
| 2025 Q2 | 33,351,676 | $375,205,711 | +$29,774,145 | $11.25 | 164 |
| 2025 Q1 | 32,270,574 | $183,952,552 | -$9,250,058 | $5.70 | 161 |
| 2024 Q4 | 32,503,442 | $318,897,469 | +$61,080,938 | $9.82 | 159 |
| 2024 Q3 | 26,309,917 | $214,342,391 | +$204,195,165 | $8.15 | 146 |
| 2024 Q2 | 12,000 | $4,012 | +$4,012 | $0.33 | 1 |